Walleye Capital
CRDF icon

Walleye Capital’s Cardiff Oncology CRDF Stock Holding History

Walleye Capital’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-123,305
Closed -$306K – 2419
2022
Q1 		$306K Buy
+123,305
New +$436K 0.01% 1301
2021
Q4 		– Sell
-14,245
Closed -$95K – 2137
2021
Q3 		$95K Buy
+14,245
New +$89.5K ﹤0.01% 1343

Other funds holding CRDF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Walleye Capital's CRDF Position: Q2 2022 in Review

Walleye Capital sold out of Cardiff Oncology (CRDF) in Q2 2022, closing a stake of 123,305 shares — an estimated $306K sold.

Walleye Capital first reported a position in CRDF in Q3 2021 and held it in 2 quarters. The position peaked at $306K in Q1 2022. 67 funds tracked by Wall St. Rank hold CRDF as of Q2 2022.

  • Walleye Capital reported no remaining Cardiff Oncology position as of Q2 2022 after selling out during the quarter.
  • Walleye Capital sold 123,305 Cardiff Oncology shares in Q2 2022, an estimated $306K.
  • Walleye Capital first reported a position in Cardiff Oncology in Q3 2021 and held it in 2 quarters.
  • Walleye Capital's Cardiff Oncology position peaked at $306K in Q1 2022.
  • 67 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2022.

Based on Walleye Capital's 13F filing for Q2 2022, filed 8 Aug 2022.